All Clinical Trials
View all active clinical trials around the US.
Elotuzumab + Iberdomide + Dexamethasone Post Ide-Cel in RRMM
ELOTUZUMAB + IBERDOMIDE POST ABECMA
The Effect of Novel Treatments in Improving Renal Outcomes Among Patients With Light Chain Cast Nephropathy
LIGHT CHAIN CAST NEPHROPATHY IN MYELOMA PATIENTS
Supportive Transfusion Program for Patients With Hematologic Malignancies: A Cluster Randomized Trial
HEME HOSPICE - HOME TRANSFUSION PROGRAM
Untreated / Newly Diagnosed Multiple Myeloma
The following is a listing of clinical trials for patients with multiple myeloma who have been newly diagnosed or have not yet received treatment.
The Effect of Novel Treatments in Improving Renal Outcomes Among Patients With Light Chain Cast Nephropathy
LIGHT CHAIN CAST NEPHROPATHY IN MYELOMA PATIENTS
Early Relapse Multiple Myeloma
The following is a listing of clinical trials for patients with multiple myeloma who have received one to two prior lines of therapy.
The Effect of Novel Treatments in Improving Renal Outcomes Among Patients With Light Chain Cast Nephropathy
LIGHT CHAIN CAST NEPHROPATHY IN MYELOMA PATIENTS
Supportive Transfusion Program for Patients With Hematologic Malignancies: A Cluster Randomized Trial
HEME HOSPICE - HOME TRANSFUSION PROGRAM
Late Relapse Multiple Myeloma
The following is a listing of clinical trials for patients with multiple myeloma who have received three or more prior lines of therapy.
Elotuzumab + Iberdomide + Dexamethasone Post Ide-Cel in RRMM
ELOTUZUMAB + IBERDOMIDE POST ABECMA
The Effect of Novel Treatments in Improving Renal Outcomes Among Patients With Light Chain Cast Nephropathy
LIGHT CHAIN CAST NEPHROPATHY IN MYELOMA PATIENTS
Supportive Transfusion Program for Patients With Hematologic Malignancies: A Cluster Randomized Trial
HEME HOSPICE - HOME TRANSFUSION PROGRAM
Smoldering Myeloma
The following is a listing of clinical trials for patients with Smoldering Myeloma.
Monoclonal Gammopathy of Undetermined Significance (MGUS)
No active clinical trials